Need Help? Chat Now With a Live Representative!

ARG Conference News: CIS 2019 Annual Meeting in Atlanta

ARG Conference News: CIS 2019 Annual Meeting in Atlanta

ARG Conference News: CIS 2019 Annual Meeting in Atlanta

March 15, 2019

Two ARG team members will be attending the CIS Annual Meeting in Atlanta April 4-7. ARG has deep experience in and ongoing commitment to immunology clinical trials, and these traits are reflected in both conference participants.

Amber Schroeder, Project Manager

"While most CROs might have general experience in clinical research, ARG has a great deal of direct experience specifically in immunology studies. Not only does this include our Project Management team, but also our CRA, DM, Stats, and QA groups as well. We are able to use this experience and lessons learned to promote the recurrence of successful studies while mitigating any study risks for future Sponsors."


Corina Moorehead
Corina Moorehead, CRA

"Due to ARG's extensive experience and expertise with IVIG studies, we are prepared and can identify any challenges that may lay ahead. Therefore, ARG can provide guidance as to how to manage a successful trial and can also share what has worked in the past. Clinical trials require a significant amount of time and money. Understanding how IVIG studies succeed and how failure can be prevented is essential in getting the product to market faster."


Corina Moorehead
Amber and Corina are looking forward to connecting with other CIS attendees to share immunology clinical trial best practices during the three days they will be in Atlanta. If you would like to arrange a conversation, please contact clofrese@atlanticresearchgroup.com.

The Vital Role of Team Stability in Advancing Clinical Trials

The Vital Role of Team Stability in Advancing Clinical Trials

In the fast-paced world of clinical research, turnover rates are high and project continuity can be a challenge. However, at […]

March 29, 2024
Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024
ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

CHARLOTTESVILLE, VIRGINIA – ARG (Atlantic Research Group) proudly announces its ongoing collaboration with Humacyte, a leading biotechnology company, on the […]

February 23, 2024
GO TO TOP